Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model
Titel:
Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model
Auteur:
Quinn, Thomas J. Yuan, Ziqiang Adem, Asha Geha, Rula Vrikshajanani, Chakravarthy Koba, Wade Fine, Eugene Hughes, David T. Schmid, Herbert A. Libutti, Steven K.